Francesca Lecce

Francesca Lecce

Auto-generated profile, based on publicly available information

Francesca Lecce

Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Fertility and Sterility
Verified
Journal Article
Closed access
LMLudovico Muzii
Ludovico Muzii
CAChiara Achilli
Chiara Achilli
FLFrancesca Lecce
Francesca Lecce
ABAntonella Bianchi
Antonella Bianchi
SFSilvia Franceschetti
Silvia Franceschetti
PPPierluigi Benedetti Panici
Pierluigi Benedetti Panici

1 November 2016 in Gynecologic Oncology
Verified
Journal Article
Closed access
GBGiorgio Bogani
Giorgio Bogani
GFGiovanni Fucà
Giovanni Fucà
GMGiuseppa Maltese
Giuseppa Maltese
ADAntonino Ditto
Antonino Ditto
Fabio MartinelliFabio Martinelli
Fabio Martinelli
Domenica LorussoDomenica Lorusso
Domenica Lorusso

28 November 2016 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
VDViolante Di Donato
Violante Di Donato
EKEvangelos HEATHER Kontopantelis
Evangelos HEATHER Kontopantelis
GAGiovanni Aletti
Giovanni Aletti
ACAssunta Casorelli
Assunta Casorelli
IPIlaria Piacenti
Ilaria Piacenti
PPPierluigi Benedetti Panici
Pierluigi Benedetti Panici

8 April 2015 in Tumori Journal
Verified
Journal Article
Closed access
AAAlessandra Alessi
Alessandra Alessi
Fabio MartinelliFabio Martinelli
Fabio Martinelli
BPBarbara Padovano
Barbara Padovano
GSGianluca Serafini
Gianluca Serafini
Domenica LorussoDomenica Lorusso
Domenica Lorusso
FCFlavio Crippa
Flavio Crippa
Aims and background: Primary cytoreductive surgery (CRS) has a significant impact on prognosis in epithelial ovarian cancer (EOC). Patient selection is important to recognize factors limiting optimal CRS and to avoid unnecessary aggressive surgical procedures. We evaluated the contribution of fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in the presurgical identification of disease sites that may preclude EOC cytoreducibility. Methods: Patients with suspected EOC underwent 18F-FDG-PET/CT within 20 days before debulking surgery. The PET/CT results were compared with surgical findings and postsurgery histopathology in order to assess the diagnostic value. Results: Between August 2013 and January 2014, 29 patients were evaluated. The histopathology showed 23 EOC and 6 benign tumors. The FDG-PET/CT was positive (maximum standardized uptake value [SUVmax] 11.3 ± 5.4) in 21/23 (91%) patients with EOC and provided 2 false-negatives (1 mucinous and 1 clear cell carcinoma; SUVmax ≤2.8). The FDG-PET/CT was true-negative (SUVmax 2.2 ± 1.6) in 4 out of 6 patients (67%). False-positive FDG-PET results were obtained in 2 cellular fibromas (SUVmax 4.8 and 5.6). The sensitivity, specificity, and accuracy of PET/CT to characterize ovarian masses were 91%, 67%, and 86%, respectively. Among the 21 FDG-PET/CT-positive EOC, we detected factors limiting optimal CRS in 6 cases (29%): 4 hepatic hilum infiltration and 2 root mesentery involvement, confirmed at surgical exploration. The FDG-PET did not find limiting factors in the remaining 15 patients (71%) in whom optimal CRS was obtained. Conclusions: Fluorodeoxyglucose-PET/CT shows high sensitivity but suboptimal specificity in the characterization of ovarian masses. However, PET/CT may play a role in noninvasively selecting patients with EOC who can benefit from primary CRS.

24 March 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
AMAngela Musella
Angela Musella
Claudia MarchettiClaudia Marchetti
Claudia Marchetti
IPInnocenza Palaia
Innocenza Palaia
GPGiorgia Perniola
Giorgia Perniola
MGM. Giorgini
M. Giorgini
PPP. Benedetti Panici
P. Benedetti Panici

18 December 2015 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
LMLudovico Muzii
Ludovico Muzii
CAChiara Achilli
Chiara Achilli
VBValentino Bergamini
Valentino Bergamini
MCMassimo Candiani
Massimo Candiani
EGElisabetta Garavaglia
Elisabetta Garavaglia
PPPierluigi Benedetti Panici
Pierluigi Benedetti Panici
STUDY QUESTION Is the combined excisional/ablative technique for the treatment of ovarian endometriomas better than the traditional stripping technique in terms of recurrence rate? SUMMARY ANSWER There is no evidence that the combined excisional/ablative technique is better than the traditional stripping technique, as similar recurrence rates were observed for the two techniques. WHAT IS KNOWN ALREADY The stripping technique is associated with better results compared with ablative, non-excisional techniques for the treatment of ovarian endometriomas. Excisional techniques, such as stripping, have, however, been associated with reduced ovarian reserve as evaluated with anti-Mullerian hormone, and surgical techniques that better preserve the ovarian reserve are needed. STUDY DESIGN, SIZE, DURATION A prospective, multicentre, randomized blinded clinical trial was carried out on 51 patients with bilateral endometriomas larger than 3 cm. For each patient, serving as her own control, one ovary was randomized to the stripping technique and the contralateral to the combined excisional/ablative technique. Patients were enrolled between January 2013 and April 2014. PARTICIPANTS/MATERIALS, SETTING, METHODS Patients of reproductive age with pelvic pain and/or infertility affected by bilateral endometriomas larger than 3 cm were included (n = 51). The patients underwent laparoscopic removal of endometriomas with two different surgical techniques performed at either side after random assignment: complete removal by stripping on one side versus the combined technique, consisting of partial excisional cystectomy followed by completion with ablative surgery using bipolar coagulation, on the other side. Post-operative follow-up was performed at 1, 3 and 6 months after surgery for the evaluation of endometrioma recurrence (primary outcome) and of antral follicle count (AFC) and ovarian volumes (OVs) to assess ovarian reserve (secondary outcome). MAIN RESULTS AND THE ROLE OF CHANCE Recurrence rates were 5.9% for the stripping technique versus 2.0% for the combined technique (odds ratio 3.00; 95% confidence interval: 0.24–157.5; P = 0.62). AFC in the ovaries treated with the stripping technique did not differ significantly from AFC in ovaries treated with the combined technique at all follow-up visits, whereas OV was significantly lower after the combined technique at the 6-month follow-up visit (P = 0.04). LIMITATIONS, REASONS FOR CAUTION A major limitation of this study is the small sample size and particularly for ovarian reserve, the secondary outcome, for which no formal sample size calculation was performed. The lower-than-expected recurrence rates in the present series may be related to the shorter follow-up in our study compared with most studies in the literature. Further studies with larger sample sizes and longer follow-up are needed to confirm the findings of this study. The combined technique using CO2 laser energy instead of bipolar coagulation should also be evaluated. WIDER IMPLICATIONS OF THE FINDINGS The traditional excisional technique, i.e. the stripping technique, should still be considered the gold standard approach for the surgical treatment of endometriomas. STUDY FUNDING/COMPETING INTEREST(S) No commercial funding was received. The authors report no relevant conflict of interest. TRIAL REGISTRATION NUMBER ANZCTR number ACTRN12614000653662. TRIAL REGISTRATION DATE 23 June 2014. DATE OF FIRST PATIENT'S ENROLMENT 1 January 2013.